Behavioral and Cardiopulmonary Effects of a Constant Rate Infusion of Remifentanil–Xylazine for Sedation in Horses
- 1 August 2020
- journal article
- research article
- Published by Elsevier in Journal of Equine Veterinary Science
- Vol. 91, 103111
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Assessment of the sedative effects of buprenorphine administered with 20 μg/kg detomidine in horsesVeterinary Record, 2011
- Comparison of the effects of the alpha-2 agonists detomidine, romifidine and xylazine on nociceptive withdrawal reflex and temporal summation in horsesVeterinary Anaesthesia and Analgesia, 2009
- Effects of buprenorphine on nociception and spontaneous locomotor activity in horsesAmerican Journal of Veterinary Research, 2007
- Equine perioperative fatalities associated with general anaesthesia at a private practice – a retrospective case seriesVeterinary Anaesthesia and Analgesia, 2007
- The confidential enquiry into perioperative equine fatalities (CEPEF): mortality results of Phases 1 and 2Veterinary Anaesthesia and Analgesia, 2002
- Diagnosing and treating pain in the horseVeterinary Clinics of North America: Equine Practice, 2002
- Cardiovascular Effects of Medetomidine, Detomidine and Xylazine in Horses.Journal of Veterinary Medical Science, 2000
- The pharmacokinetics of remifentanilJournal of Clinical Anesthesia, 1996
- Remifentanil Pharmacokinetics and PharmacodynamicsClinical Pharmacokinetics, 1995
- A comparison of the sedative effects of three α2‐adrenoceptor agonists (romifidine, detomidine and xylazine) in the horseJournal of Veterinary Pharmacology and Therapeutics, 1992